The Possible Roles of Prostaglandins and Related Compounds in Endometrial Bleeding a mini-review

References

• Abel M. H., Baird D. T. The effect of 17β-estradiol and progesterone on prostaglandin production by human endometrium maintained in organ culture. Endocrinology 1980; 106: 1599
   PubMed Web of Science ®Google Scholar
• Abel M. H., Kelly R. W. Differential production of prostaglandins within the human uterus. Prostaglandins 1979; 18: 821
   Google Scholar
• Abel M. H., Smith S. K., Baird D. T. Suppression of concentration of endometrial prostaglandin in early intrauterine and ectopic pregnancy in women. J Endocrinol 1980; 85: 379
   Google Scholar
• Ali M., McDonald J. W. D. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclo-oxygenase activity. Prostaglandins Med 1979; 3: 327
   PubMedGoogle Scholar
• Anderson A. B. M., Haynes P. J., Guillebaud J., Turnbull A. C. Reduction of menstrual blood loss by prostaglandin synthetase inhibitors. Lancet 1976; i: 774
   Google Scholar
• Aspirin Myocardial Infarction Study Research Group. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980; 243: 661
   PubMed Web of Science ®Google Scholar
• Bartelmez G. W. The human uterine mucous membrane during menstruation. Am J Obstet Gynecol 1931; 21: 623
   Google Scholar
• Bartelmez G. W. Histologic studies on the menstruating mucous membrane of the human uterus. Contrib Embryo1 1933; 142: 142
   Google Scholar
• Borgeat P., Samuelsson B. Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid. J Biol Chem 1979; 254: 2643
   PubMed Web of Science ®Google Scholar
• Borgeat P., Sirois P. Leukotrienes: A major step in the understanding of immediate hypersensitivity reactions. J Med Chem 1981; 24: 121
   PubMed Web of Science ®Google Scholar
• Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Naproxen up to date: a review of its pharmacological and therapeutic efficacy and use in rheumatic diseases and pain states. Drugs 1979; 18: 241
   PubMed Web of Science ®Google Scholar
• Bunting S., Gryglewski R., Moncada S., Vane J. R. Arterial walls generate from prostaglandin endo-peroxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976; 12: 897
   PubMed Web of Science ®Google Scholar
• Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53
   PubMed Web of Science ®Google Scholar
• de Castellarnau C., Cerletti C., Dejana E., Galletti F., Latini R., Livio M., de Gaetano G. Salicylate-aspirin interaction and thrombosis prevention trials. Thromb Haemostas 1981; 45: 294
   PubMedGoogle Scholar
• Christiaens G. C. M. L. Menstrual haemostasis with and without intrauterine device. Dissertation, Elinkwijk BV, UtrechtBelgium 1981
   Google Scholar
• Christiaens G. C. M. L., Sixma J. J., Haspels A. A. Morphology of hemostasis in menstrual endometrium. Br J Obstet Gynaecol 1980; 87: 425
   PubMedGoogle Scholar
• Christaens G. C. M. L., Sixma J. J., Haspels A. A. Haemostasis in menstrual endometrium in the presence of an intrauterine device. Br J Obstet Gynaecol 1981; 88: 825
   Google Scholar
• Collier H. O. J., Sweatman W. J. Antagonism by fenemates of prostaglandin F2α and of slow reacting substance on human bronchial muscle. Nature 1968; 219: 864
   Web of Science ®Google Scholar
• Davies A. J., Anderson A. B. M., Turnbull A. C. Reduction by naproxen of excessive menstrual bleeding in women using intrauterine devices. Obstet Gynecol 1981; 57: 74
   PubMed Web of Science ®Google Scholar
• Dahlén S.-E., Björk J., Hedqvist P., Arfors K.-E., Hammarström S., Lindgren J.-Å., Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981; 78: 3887
   PubMed Web of Science ®Google Scholar
• Dahlén S.-E., Hedqvist P., Björk J. Pulmonary and cardiovascular pharmacology of leukotrienes. NATO Advanced Studies Series, International School of Pharmacology. Leukotrienes and Prostacyclin, F. Berti, G. C. Folco, G. P. Velo. Plenum Press, New York, In press
   Google Scholar
• Endometrial Bleeding and Steroidal Contraception. Proceedings of a Symposium on Steroid Contraception and Mechanisms of Endometrial Bleeding, organized by the World Health Organization in Geneva, an 12–14 September 1979, E. Diczfalusy, I. S. Fraser, F. T. G. Webb. Pitman Press Ltd., BathEngland 1980
   Google Scholar
• Editorial. Aspirin after myocardial infarction. Lancet 1980; i: 1172
   Google Scholar
• Fields W. S., Lemak N. A., Frankowski R. F., Hardy R. J. Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8: 310
   Google Scholar
• Ford-Hutchinson A. W., Bray M. A., Doig M. E., Smith M. J. H. Leukotriene B2 a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264
   PubMed Web of Science ®Google Scholar
• Gerrard J. M., White J. G. Prostaglandins and thromboxanes: “Middlemen” modulating platelet function in hemostasis and thrombosis. Progr Hemostasis Thromb 1978; 4: 87
   Google Scholar
• Goetzl E. J., Woods J. N., Gorman R. R. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetranoic acid (HETE). J Clin Invest 1977; 59: 179
   PubMed Web of Science ®Google Scholar
• Granström E. The prostaglandins, thromboxanes and leukotrienes. Acta Obstet Gynecol Scand Suppl
   Google Scholar
• Granström E., Kindahl H. Radioimmunoassay of prostaglandins and thromboxanes. Adv Prostaglandin Thromboxane Res 1978; 5: 119
   PubMedGoogle Scholar
• Greén K., Hagenfeldt K. Prostaglandins in the human endometrium. Gas chromatographic-mass spectrometric quantitation before and after IUD insertion. Am J Obstet Gynecol 1975; 122: 611
   PubMedGoogle Scholar
• Guillebaud J., Anderson A. G. M., Turnbull A. C. Reduction by mefenamic acid of increased menstrual blood loss associated with intrauterine contraception. Br J Obstet Gynaecol 1978; 85: 53
   PubMedGoogle Scholar
• Hagenfeldt K. (1980) Prostaglandins and related compounds and their metabolism in normal and steroid-exposed endometrium. Endometrial Bleeding and Steroidal Contraception. Proceedings of a Symposium on Steroid Contraception and Mechanisms of Endometrial Bleeding, organized by the World Health Organization in Geneva. September, 12–141979, E. Diczfalusy, I. S. Fraser, F. T. G. Webb. Pitman Press Ltd., BathEngland, 222–239
   Google Scholar
• Hahn L., Petruson B. The influence of acetylsalicylic acid and paracetamol on menstrual blood loss in women with and without an intrauterine contraceptive device. Am J Obstet Gynecol 1979; 135: 393
   Google Scholar
• Hamberg M., Samuelsson B. Prostaglandin endo-peroxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 1974; 71: 3400
   PubMed Web of Science ®Google Scholar
• Hamberg M., Svensson J., Samuelsson B. Prostaglandin endoperoxides: A new concept concerning the mode of action and release of prostaglandins. Proc Natl Acad Sci USA 1974; 71: 3824
   PubMed Web of Science ®Google Scholar
• Hamberg M., Svensson J., Samuelsson B. Thromboxane: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 72: 2994
   PubMed Web of Science ®Google Scholar
• Hamberg M., Svensson J., Wakabayashi T., Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci USA 1974; 71: 345
   PubMed Web of Science ®Google Scholar
• Haynes P. J., Flint A. P. F., Hodgson H., Anderson A. B. M., Dray F., Turnbull A. C. Studies in menorrhagia: (a) mefenamic acid, (b) endometrial prostaglandin concentrations. Int J Gynaecol Obstet 1980; 17: 367
   Google Scholar
• Hillier K., Kasonde J. M. Prostaglandin E and F concentrations in human endometrium after insertion of intrauterine contraceptive device. Lancet 1976; i: 15
   Google Scholar
• Holmsen H. Prostaglandin endoperoxide-thromboxane synthesis and dense granule secretion as positive feedback loops in the propagation of platelet responses during “the basic platelet reaction”. Thromb Haemostas 1977; 38: 1030
   PubMed Web of Science ®Google Scholar
• Jakubowitz D. L., Wood C. The use of the prostaglandin synthetase inhibitor mefenamic acid in the treatment of menorrhagia. Aust NZ J Obstet Gynaecol 1978; 18: 135
   Google Scholar
• Johnson R. A., Morton D. R., Kinner J. H., Gorman R. R., McGuire J. C., Sun F. F., Whittaker N., Bunting S., Salmon J., Moncada S., Vane J. R. The chemical structure of prostaglandin X (prostacyclin). Prostaglandins 1976; 12: 915
   PubMed Web of Science ®Google Scholar
• Lundberg U., Rådmark O., Malmsten C., Samuelsson B. Transformation of 15-hydroxyperoxy-5,9,11,13-eicosatetraenoic acid into novel leukotrienes. FEBS Lett 1981; 126: 127
   PubMedGoogle Scholar
• Lundström V., Green K. Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women. Am J Obstet Gynecol 1978; 130: 640
   PubMed Web of Science ®Google Scholar
• Lundström V., Gréen K., Svanborg K. Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility. Acta Obstet Gynecol Scand Suppl 1979; 87: 51
   Google Scholar
• Marcus A. J. The role of lipids in platelet function: with particular reference to the arachidonic acid pathway. J Lipid Res 1978; 19: 793
   PubMed Web of Science ®Google Scholar
• Markee J. E. Menstruation in intraocular endometrial transplants in the rhesus monkey. Contrib Embryol 1940; 177: 221
   Google Scholar
• Markee J. E. Morphological basis for menstrual bleeding. Relation of regression to the initiation of bleeding. Bull NY Acad Med 1948; 24: 253
   Google Scholar
• McNicol G. P. Antiplatelet drugs in the secondary prevention of myocardial infarction. Lancet 1980; ii: 736
   Google Scholar
• Merino J., Livio M., Rajtar G., de Gaetano O. Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation. Biochem Pharmacol 1980; 29: 1093
   PubMed Web of Science ®Google Scholar
• Moncada S., Amezcua J. L. Prostacyclin, thromboxane A2 interaction in haemostasis and thrombosis. Haemostasis 1979; 8: 252
   Google Scholar
• Moncada S., Vane J. R. Mode of action of aspirin-like drugs. Adv Intern Med 1979; 24: 1
   PubMedGoogle Scholar
• Mustard J. F., Kinlough-Rathbone R. L., Packham M. A. Prostaglandins and platelets. Ann Rev Med 1980; 31: 89
   Google Scholar
• Nadell J., Bruno J., Varady J., Segre E. J. Effect of naproxen and of aspirin on bleeding time and platelet aggregation. J Clin Pharmacol 1974; 14: 176
   PubMedGoogle Scholar
• Packham M. A., Mustard J. F. Pharmacology of platelet affecting drugs. Circulation (Suppl V) 1980; 62: V26–V40
   Google Scholar
• Paton R. C., Tindall H., Zuzel M., McNicol G. P. (1980) Haemostatic mechanisms in the normal endometrium and endometrium exposed to contraceptive steroids. Endometrial Bleeding and Steroidal Contraception. Proceedings of a Symposium on Steroid Contraception and Mechanisms of Endometrial Bleeding, organized by the World Health Organization in Geneva. September, 12–141979, E. Diczfalusy, I. S. Fraser, F. T. G. Webb. Pitman Press Ltd., BathEngland, 325–341
   Google Scholar
• Petruson B., Hahn L., Korsan-Bengtsen K., Hallberg L. Influence of acetylsalicylic acid and paracetamol on menstrual blood loss. Haemestasis 1977; 6: 266
   Google Scholar
• Ross R., Glomset J., Kariya B., Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 1974; 71: 1207
   PubMed Web of Science ®Google Scholar
• Roth G. J., Stanford N., Majerus P. Acetylation of prostaglandin synthetase by aspirin. Proc Natl Acad Sci USA 1975; 72: 3073
   PubMed Web of Science ®Google Scholar
• Samuelsson B., Borneat P., Hammarström S., Murphy R. C. Leukotrienes: A new group of biologically active compounds. Adv Prostaglandin Thromboxane Res 1980; 6: 1
   PubMedGoogle Scholar
• Samuelsson B., Hammarström S., Murphy R. C., Borgeat P. Leukotrienes and slow reacting substance of anaphylaxis (SRS-A). Allergy 1980; 35: 375
   PubMed Web of Science ®Google Scholar
• Sheppard B. L., Bonnar J. Scanning and transmission electron microscopy of material adherent to intra-uterine contraceptive devices. Br J Obstet Gynaecol 1980; 87: 155
   Google Scholar
• Smith J. B. The prostanoids in hemostasis and thrombosis: a review. Am J Pathol 1980; 99: 743
   Google Scholar
• Smith J. B., Araki M., Lefer A. M. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation. Circulation (Suppl V) 1980; 62: V19–V25
   PubMed Web of Science ®Google Scholar
• Smith J. B., Willis A. L. Aspirin selectively inhibits prostaglandin production in human platelets. Nature New Biol 1971; 231: 235
   PubMedGoogle Scholar
• Smith S. K., Abel M. H., Kelly R. W., Bacid D. T. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981; 88: 434
   PubMedGoogle Scholar
• Smith S. K., Abel M. H., Kelly R. W., Bacid D. T. A role for prostacyclin (PGI2) in excessive menstrual bleeding. Lancet 1981; i: 522
   Google Scholar
• Taylor F. B., Jr., Müller-Eberhardt H. J. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets. J Clin invest 1970; 49: 2068
   Google Scholar
• Vargaftig B. B. The inhibiton of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines. Eur J Pharmacol 1978; 50: 231
   PubMed Web of Science ®Google Scholar
• Wester J., Sixma J. J., Genze J. J., Van der Veen J. Morphology of the early hemostasis in human skin wounds. Influence of acetylsalicylic acid. Lab Invest 1978; 39: 298
   PubMed Web of Science ®Google Scholar
• Willman E. A., Collins W. P., Clayton S. G. Studies in the involvement of prostaglandins in uterine symptomatology and pathology. Br J Obstet Gynaecol 1976; 83: 337
   PubMedGoogle Scholar
• Ylikorkala O., Kauppila A., Siljander M. Anti-prostaglandin therapy in prevention of side-effects of intra-uterine contraceptive devices. Lancet 1978; i: 393
   Google Scholar
• Zucker M. B. The value of the blood platelet in hemostasis and as a scientific tool. Trans NY Acad Sci Series II 1974; 36: 561
   Google Scholar